Neurological & CognitiveStudiedIntl. Approved (Russia)

Selank

Tuftsin Analog TP-7 · Enkephalinase (neprilysin) inhibition extending endogenous enkephalin activity; modulation of serotonin, dopamine, and GABA systems; normalization of IL-6; inhibition of HIF-1α expression in stress conditions; indirect GABAergic effects

Not medical advice. For educational and research reference only.

Typical Dose

250–500 mcg intranasally 2–3× daily

Route

Intranasal

Cycle

2–4 week cycles

Storage

2–8°C Refrigerated

What is Selank?

Selank is a synthetic heptapeptide anxiolytic based on the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), developed and approved in Russia for generalized anxiety disorder and as an immunomodulator. It demonstrates anxiolytic and nootropic effects comparable to benzodiazepines but without the sedation, dependence potential, or memory impairment. Administered intranasally. Not FDA-approved in the US.

Mechanism of Action

Enkephalinase (neprilysin) inhibition extending endogenous enkephalin activity; modulation of serotonin, dopamine, and GABA systems; normalization of IL-6; inhibition of HIF-1α expression in stress conditions; indirect GABAergic effects

Target: Enkephalinase (neprilysin), serotonergic system, GABA modulation

Research Indications

Cognitive FunctionEffective

Research suggests improvements in memory, focus, and cognitive processing

NeuroprotectionModerate

May protect neurons from oxidative stress and inflammatory damage

Mood & AnxietyModerate

Some studies report anxiolytic and mood-stabilizing effects

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow doseOnce dailyIntranasal or Injectable
Standard DoseStandardOnce dailyIntranasal or Injectable

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Stimulants (Modafinil, Adderall)Caution
MAOIs / SSRIsMonitor
RacetamsCaution
NAD+Compatible
BPC-157Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove Selank vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Subtle mood and focus improvements may begin. Sleep quality often improves early.

Week 2–4

Increased mental clarity, word recall, and reduced brain fog reported by many.

Week 4–8

Consistent cognitive improvements. Better stress response and working memory.

Week 8+

Sustained cognitive and neurological benefits. Effects may persist post-cycle.

Side Effects & Safety

  • Headache, particularly at initiation
  • Mild anxiety or restlessness with some compounds
  • Nasal irritation (intranasal administration)
  • Sleep disturbance if dosed too close to bedtime
  • Rare: Mood changes or emotional lability

FDA Status & Regulatory Info

Intl. Approved (Russia)

Selank is a synthetic heptapeptide anxiolytic based on the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg), developed and approved in Russia for generalized anxiety disorder and as an immunomodulator. It demonstrates anxiolytic and nootropic effects comparable to benzodiazepines but without the sedation, dependence potential, or memory impairment. Administered intranasally. Not FDA-approved in the US.

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Research References

External links for education only. We do not control third-party content.

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

Community Intelligence

What 57 users report

57 community reports

Positive 3% · Neutral 97% · Negative 0%

Most reported benefits

Mood
184
Recovery
184

Most reported side effects

Injection site irritation
94
Fatigue
85

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
0
100–200
3
200–400
96
400–600
76
600–1000
5
1000–2000
2
2000+
2

How repeat users are trending

Among repeat reporters, 86% said they felt similar to their last entry, 14% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 54 days · Based on 35 repeat reporters

Share Your Experience

Rate Selank in the PeptIQ app and help the community make informed decisions.

Research purposes only

This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.